To report a previously unknown adverse drug reaction, the nurse practitioner should ...

To report a previously unknown adverse drug reaction, the nurse practitioner should ...

• A. access the BPCA website.
• B. call the PREA hotline.
• C. log onto the FDA MedWatch website.
• D. use the AAP online PediaLink program.

Answer: (C)

Reporting unknown adverse drug reactions is a key part of pharmacovigilance. The FDA MedWatch system is the official channel for healthcare professionals to report suspected adverse events, including reactions that haven’t been previously described. You can submit reports online or by phone, and you’ll provide details such as the drug involved, the reaction, patient age, onset, seriousness, and the outcome. These reports help FDA detect safety signals, inform labeling changes, and improve patient safety overall. Other options don’t fit this purpose. The BPCA site focuses on pediatric drug safety research and labeling considerations, not direct ADR reporting. The PREA hotline relates to pediatric research regulatory matters rather than pharmacovigilance reporting. PediaLink is an educational resource, not a mechanism for reporting adverse drug reactions.

Reporting unknown adverse drug reactions is a key part of pharmacovigilance. The FDA MedWatch system is the official channel for healthcare professionals to report suspected adverse events, including reactions that haven’t been previously described. You can submit reports online or by phone, and you’ll provide details such as the drug involved, the reaction, patient age, onset, seriousness, and the outcome. These reports help FDA detect safety signals, inform labeling changes, and improve patient safety overall.

Other options don’t fit this purpose. The BPCA site focuses on pediatric drug safety research and labeling considerations, not direct ADR reporting. The PREA hotline relates to pediatric research regulatory matters rather than pharmacovigilance reporting. PediaLink is an educational resource, not a mechanism for reporting adverse drug reactions.